(1)
Bellone, M.; Sabinot, A.; D’Arpino, A.; Omodeo Salè, E.; Ghislieri, D.; Pradelli, L. A 1-Year Per-Patient Cost of Therapy Administration Analysis of Mosunetuzumab and Tisagenlecleucel in Relapsed or Refractory Follicular Lymphoma Patients Receiving Two or More Lines of Systemic Therapy. Grhta 2024, 11, 239-247.